HSDT
Solana CompanyNASDAQHealthcare$1.86+9.41%ClosedMarket Cap: $75.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
136.28
P/S
12.46
EV/EBITDA
-1.68
DCF Value
$-11.95
FCF Yield
-22.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
91.7%
Operating Margin
-4052.5%
Net Margin
-679.6%
ROE
113.0%
ROA
-13.5%
ROIC
-81.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.2M | 96.6% | $-8.9M | $325.5M | $36.45 | — |
| FY 2025 | $6.0M | 91.7% | $-21.1M | $-40.9M | $-1.85 | — |
| Q3 2025 | $697.0K | 85.2% | $-4.9M | $-352.8M | $-32.89 | — |
| Q2 2025 | $43.0K | -123.3% | $-3.3M | $-9.8M | $-3.99 | — |
| Q1 2025 | $49.0K | -146.9% | $-4.0M | $-3.8M | $-1.42 | — |
| Q4 2024 | $152.0K | -1.3% | $-3.1M | $-3.9M | $-1.45 | — |
| FY 2024 | $520.0K | -11.9% | $-13.9M | $-11.7M | $-4.33 | — |
| Q3 2024 | $51.0K | -266.7% | $-4.1M | $-3.7M | $-0.99 | — |
| Q2 2024 | $182.0K | 35.2% | $-3.3M | $-1.6M | $-0.64 | — |
| Q1 2024 | $135.0K | 8.9% | $-3.4M | $-2.5M | $-1.54 | — |
| Q4 2023 | $134.0K | 32.8% | $-2.2M | $-1.0M | $-0.73 | — |
| FY 2023 | $644.0K | 9.5% | $-12.4M | $-8.8M | $-7.28 | — |